Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Rikard Johnsen

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Ugeskrift for Laeger|September 5, 2025
[Occupational cockroach allergy]Louise Parke, Claus Rikard Johnsen, Stinna Skaaby
Ugeskrift for Laeger|July 13, 2016
[Pharmacological therapy of asthma during pregnancy]Iram Akram, Charlotte Suppli Ulrik, Claus Rikard Johnsen
Ugeskrift for Laeger|April 21, 2016
[Specific bronchial and nasal provocations with work-related allergens]David Sherson, Jesper Bælum, Claus Rikard Johnsen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 21, 2026
National and Individual-Level Economic Burden of Local Corticosteroid Use and Concomitant Use of Multiple Local Corticosteroid Formulations-A Nationwide Cohort StudyKjell Erik Julius Håkansson, Jonas Bækdal, Inge Raadal Skov, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 13, 2023
Tobacco Exposure and Efficacy of Biologic Therapy in Patients With Severe Asthma: A Nationwide Study From the Danish Severe Asthma RegisterMarianne Baastrup Soendergaard, Susanne Hansen, Anne-Sofie Bjerrum, et al.
ERJ Open Research|March 18, 2026
Cumulative corticosteroid burden over 25 years in patients initiating biologic therapy for severe asthma: a nationwide cohort studyGalathea Berner, Marianne Baastrup Soendergaard, Susanne Hansen, et al.
Allergy|December 14, 2024
Early Reduction of FeNO on Anti-IL5 Biologics Is Associated With Clinical Remission of Severe AsthmaMarianne Baastrup Soendergaard, Susanne Hansen, Kjell Erik Julius Håkansson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 13, 2025
Tezepelumab in Real-Life Practice: Characteristics of Patients Commenced and Efficacy in a Nationwide, Danish Cohort of Patients With Severe AsthmaMarianne Baastrup Soendergaard, Kjell Erik Julius Haakansson, Susanne Hansen, et al.
Lung|March 12, 2025
Supratherapeutic Inhaled Corticosteroid Use in Patients Initiating on Biologic Therapies for Severe Asthma: A Nationwide Cohort StudyFrederikke Hjortdahl, Marianne Baastrup Soendergaard, Susanne Hansen, et al.
The European Respiratory Journal|January 9, 2025
Pre-biologic disease trajectories are associated with morbidity burden and biologic treatment response in severe asthmaMarianne Baastrup Soendergaard, Frederikke Hjortdahl, Susanne Hansen, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|September 5, 2025
[Occupational cockroach allergy]Louise Parke, Claus Rikard Johnsen, Stinna Skaaby
Ugeskrift for Laeger|July 13, 2016
[Pharmacological therapy of asthma during pregnancy]Iram Akram, Charlotte Suppli Ulrik, Claus Rikard Johnsen
Ugeskrift for Laeger|April 21, 2016
[Specific bronchial and nasal provocations with work-related allergens]David Sherson, Jesper Bælum, Claus Rikard Johnsen, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 21, 2026
National and Individual-Level Economic Burden of Local Corticosteroid Use and Concomitant Use of Multiple Local Corticosteroid Formulations-A Nationwide Cohort StudyKjell Erik Julius Håkansson, Jonas Bækdal, Inge Raadal Skov, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 13, 2023
Tobacco Exposure and Efficacy of Biologic Therapy in Patients With Severe Asthma: A Nationwide Study From the Danish Severe Asthma RegisterMarianne Baastrup Soendergaard, Susanne Hansen, Anne-Sofie Bjerrum, et al.
ERJ Open Research|March 18, 2026
Cumulative corticosteroid burden over 25 years in patients initiating biologic therapy for severe asthma: a nationwide cohort studyGalathea Berner, Marianne Baastrup Soendergaard, Susanne Hansen, et al.
Allergy|December 14, 2024
Early Reduction of FeNO on Anti-IL5 Biologics Is Associated With Clinical Remission of Severe AsthmaMarianne Baastrup Soendergaard, Susanne Hansen, Kjell Erik Julius Håkansson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 13, 2025
Tezepelumab in Real-Life Practice: Characteristics of Patients Commenced and Efficacy in a Nationwide, Danish Cohort of Patients With Severe AsthmaMarianne Baastrup Soendergaard, Kjell Erik Julius Haakansson, Susanne Hansen, et al.
Lung|March 12, 2025
Supratherapeutic Inhaled Corticosteroid Use in Patients Initiating on Biologic Therapies for Severe Asthma: A Nationwide Cohort StudyFrederikke Hjortdahl, Marianne Baastrup Soendergaard, Susanne Hansen, et al.
The European Respiratory Journal|January 9, 2025
Pre-biologic disease trajectories are associated with morbidity burden and biologic treatment response in severe asthmaMarianne Baastrup Soendergaard, Frederikke Hjortdahl, Susanne Hansen, et al.
Pageof 2